“Maybe this getting older thing just sucks and that’s how it is.”
Anschutz Cancer Pavilion
1665 North Aurora Court
Aurora, CO 80045
In an 8-4 vote, the FDA’s Oncologic Drugs Advisory Committee Roster voted against the benefit-risk profile of Secura Bio’s P13K inhibitor Copiktra.
Two CU Cancer Center members detail how the Supreme Court decision in Dobbs V. Jackson Women’s Health Organization will harm some patients.
A novel imaging information system developed by researchers at CU Anschutz may eventually provide a faster, more accurate prognosis for certain tumors.
CU Cancer Center researchers have discovered how to extract critical information about breast cancer tumors and disease progression by analyzing blood plasma.